<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupKathryn Alsop, Gillian Mitchell, Michael J. Birrer et al.|Journal of Clinical Oncology|2012Cited by 1.2k
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G.W. Verhaak, Matthew Meyerson, Pablo Tamayo et al.|Journal of Clinical Investigation|2012Cited by 591
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerFrancisco José Cândido dos Reis, Honglin Song, Ellen L. Goode et al.|Clinical Cancer Research|2014Cited by 160
Interferon-ε is a tumour suppressor and restricts ovarian cancerZoe R. C. Marks, Paul J. Hertzog, Nicole K. Campbell et al.|Nature|2023Cited by 70